χ-sepnet: Deep neural network for magnetic susceptibility source separation

Minjun Kim,Sooyeon Ji,Jiye Kim,Kyeongseon Min,Hwihun Jeong,Jonghyo Youn,Taechang Kim,Jinhee Jang,Berkin Bilgic,Hyeong-Geol Shin,Jongho Lee
2024-10-21
Abstract:Magnetic susceptibility source separation ($\chi$-separation), an advanced quantitative susceptibility mapping (QSM) method, enables the separate estimation of para- and diamagnetic susceptibility source distributions in the brain. The method utilizes reversible transverse relaxation (R2'=R2*-R2) to complement frequency shift information for estimating susceptibility source concentrations, requiring time-consuming data acquisition for R2 in addition R2*. To address this challenge, we develop a new deep learning network, $\chi$-sepnet, and propose two deep learning-based susceptibility source separation pipelines, $\chi$-sepnet-R2' for inputs with multi-echo GRE and multi-echo spin-echo, and $\chi$-sepnet-R2* for input with multi-echo GRE only. $\chi$-sepnet is trained using multiple head orientation data that provide streaking artifact-free labels, generating high-quality $\chi$-separation maps. The evaluation of the pipelines encompasses both qualitative and quantitative assessments in healthy subjects, and visual inspection of lesion characteristics in multiple sclerosis patients. The susceptibility source-separated maps of the proposed pipelines delineate detailed brain structures with substantially reduced artifacts compared to those from conventional regularization-based reconstruction methods. In quantitative analysis, $\chi$-sepnet-R2' achieves the best outcomes followed by $\chi$-sepnet-R2*, outperforming the conventional methods. When the lesions of multiple sclerosis patients are assessed, both pipelines report identical lesion characteristics in most lesions ($\chi$para: 99.6% and $\chi$dia: 98.4% out of 250 lesions). The $\chi$-sepnet-R2* pipeline, which only requires multi-echo GRE data, has demonstrated its potential to offer broad clinical and scientific applications, although further evaluations for various diseases and pathological conditions are necessary.
Image and Video Processing
What problem does this paper attempt to address?
The problem that this paper attempts to solve is how to more accurately separate the magnetic susceptibility source distributions of paramagnetic and diamagnetic substances in brain magnetic resonance imaging. Specifically, the paper proposes two deep - learning - based magnetic susceptibility source separation pipelines (χ - sepnet - 𝑅2′ and χ - sepnet - 𝑅2∗), aiming to overcome two main challenges in traditional methods: 1. **Streaking Artifact Problem**: When dealing with single - head - position data, traditional magnetic susceptibility source separation methods are prone to produce so - called streaking artifacts due to the ill - conditioned dipole inversion problem. These artifacts will affect the quality and accuracy of the image. 2. **Excessively Long Data Acquisition Time**: Existing methods usually require multi - echo GRE data and multi - echo spin - echo (SE) or turbo - spin - echo (TSE) data to estimate 𝑅2′, which increases the time cost of data acquisition. In particular, the acquisition of multi - echo SE data is very time - consuming. To solve these problems, the paper proposes the following solutions: - **χ - sepnet - 𝑅2′**: This pipeline uses multi - echo GRE data and multi - echo SE (or TSE) data as input to generate high - quality magnetic susceptibility source separation maps. - **χ - sepnet - 𝑅2∗**: This pipeline only requires multi - echo GRE data as input, and synthesizes the 𝑅2′ map from the 𝑅2∗ map through another deep neural network R2PRIMEnet, thereby generating a magnetic susceptibility source separation map. Through deep - learning techniques, these two pipelines can not only effectively suppress streaking artifacts and improve image quality, but also reduce data acquisition time, making them more practical in clinical applications. The paper verifies the effectiveness and feasibility of these two pipelines through in - vivo data of healthy subjects and patients with multiple sclerosis.